SCHEMBL9029220

SCHEMBL9029220

CCN(CC)CC#CCNC(C)=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 5/20 0.61
CHRM2 P08172 3/20 0.61
CHRM4 P08173 3/20 0.61
CHRM5 P08912 3/20 0.61
CHRM3 P20309 3/20 0.61
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
GAA P10253 1/20 0.41
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34
HIF1A Q16665 1/20 0.34
NFKB1 P19838 1/20 0.33
KCNH2 Q12809 1/20 0.33
SOST Q9BQB4 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPY2R P49146 1/20 0.33
PAOX Q6QHF9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11723269 0.84 CHRM1 (0.44) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL11727498 0.76 KDM4E (0.45) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL10257125 0.75 CHRM2 (0.59) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL9030861 0.74 CHRM1 (0.55) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL9029298 0.74 CHRM1 (0.72) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL13978172 0.74
SCHEMBL16425174 0.74 KDM4E (0.42) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL9030866 0.72 CHRM1 (0.48) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL9029974 0.72
SCHEMBL28303485 0.72 NPSR1 (0.41) CHRM1CHRM2CHRM4CHRM5CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0426714-B1 ACETYLENIC IMIDAZOLES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1996-04-03 EP disclosed
US-5100909-A Cholinergic antagonists, analgesics, treatment of Alzheimer*s disease THE UPJOHN COMPANY (US) 1992-03-31 US disclosed
EP-0426714-A1 ACETYLENIC IMIDAZOLES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1991-05-15 EP disclosed
WO-1990001026-A1 ACETYLENIC IMIDAZOLES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-02-08 WO disclosed